What this category follows, tests and measures.

Coverage scope

Biotechnology platforms, tools and products where scientific progress may translate into adoption, revenue and durable operating leverage.

Evidence that matters

Clinical and analytical validation, regulatory milestones, reimbursement, customer adoption, test or product volume, margins and cash requirements.

How companies are selected

Companies enter coverage when a defined catalyst can be preregistered and measured against primary-source commercial evidence.